Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1983
|
| gptkbp:ATCCode |
gptkb:N06AB08
|
| gptkbp:brand |
gptkb:fluvoxamine
|
| gptkbp:CASNumber |
61718-82-9
|
| gptkbp:chemicalFormula |
C15H21F3N2O2
|
| gptkbp:contraindication |
concomitant use with MAOIs
|
| gptkbp:drugClass |
selective serotonin reuptake inhibitor
|
| gptkbp:eliminationHalfLife |
15-22 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Faverin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Abbott_Laboratories
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
C (US) |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache insomnia sexual dysfunction |
| gptkbp:synonym |
gptkb:Luvox
|
| gptkbp:usedFor |
gptkb:depression
gptkb:obsessive-compulsive_disorder |
| gptkbp:bfsParent |
gptkb:fluvoxamine
|
| gptkbp:bfsLayer |
6
|